<DOC>
	<DOCNO>NCT01944852</DOCNO>
	<brief_summary>The DIDo study open-label , randomise , multicentre study 2 parallel group incident CAPD patient age 65 minimum : - One group patient receive 2 bag icodextrin/day 1 bag glucose - One group patient receive 1 bag icodextrin/day 2 bag glucose .</brief_summary>
	<brief_title>Efficacy Safety Double Icodextrin Dose Elderly Incident CAPD Patients Incremental PD .</brief_title>
	<detailed_description>The DiDo study evaluate efficacy safety Double Icodextrin Dose elderly incident CAPD patient incremental Peritoneal Dialysis therapy . The objective demonstrate superiority safety use 2 , compare 1 , icodextrin bag / day , cohort elderly incident continuous ambulatory peritoneal dialysis ( CAPD ) patient use incremental peritoneal dialysis ( PD ) ( 3 bag / day ) , aim prolong period time incremental PD use . This phase IV open-label , randomise , multicentre study 2 parallel group , take place 30 hospital out-patient clinic un Europe . It plan include 160 patient run-in period order obtain 100 randomised patient 90 patient evaluable primary endpoint ( 45 group ) . The duration patient recruitment estimate 1 year may extend 160 patient recruit . There 2 period : run-in period 2 month treatment period 18 month .</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Icodextrin</mesh_term>
	<criteria>Runin period Incident CAPD patient require incremental PD 1.5L dialysate safely instill , Creatinine clearance &lt; 20 ml / min ( calculated modification Diet renal Disease [ MDRD ] formula ) , Age â‰¥ 65 year , Patients willing able give write informed consent comply requirement study protocol . Treatment period Patients successfully complete runin period ( achieve euvolemia ) Runin period Contraindication CAPD accord local practice , Life expectancy &lt; 6 month , Known allergy icodextrin ( cloudy dialysate skin rash ) , Need aminoacid prescription , Treatment investigational product within 30 day prior signature informed consent form ( ICF ) History drug alcohol abuse within 3 month prior signature ICF . Treatment period Severe symptomatic arterial hypotension end runin period Investigator 's opinion , Excessive ultrafiltration ( UF ) runin period , Allergy icodextrin discover runin period , Impossibility achieve adequate PD regimen within runin period ( catheter dysfunction , peritoneal leak , inadequate compliance , psychosocial reason )</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>icodextrin</keyword>
	<keyword>double dose</keyword>
	<keyword>elderly incident CAPD patient</keyword>
	<keyword>DIDo study</keyword>
</DOC>